By MATTHEW PERRONE 2010-09-02T08:01:52Z WASHINGTON (AP) -- Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug....
By MATTHEW PERRONE, Associated Press: Health
Thu, 09/02/2010 - 1:01am
By MATTHEW PERRONE 2010-09-02T08:01:52Z WASHINGTON (AP) -- Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug....